Guido Bisping
Impact in
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Oncology top 10%
- Peptidase Inhibition and Analysis
- Cancer Treatment and Pharmacology
Papers in
- Hematology 15
- Multiple Myeloma Research and Treatments 10
- Hematopoietic Stem Cell Transplantation 3
- Chronic Myeloid Leukemia Treatments 3
- Oncology 8
- Cancer Treatment and Pharmacology 3
- Co-authors
- Wolfgang E. Berdel (17 shared papers)Joachim Kienast (14 shared papers)Martin Kropff (11 shared papers)Gabriele Koehler (1 shared paper)Athanasios Tragiannidis (1 shared paper)Andreas H. Groll (1 shared paper)Nicola Lang (4 shared papers)Rolf M. Mesters (5 shared papers)
- Journals
- Blood (6 papers)Annals of Hematology (2 papers)International Journal of Cancer (2 papers)British Journal of Haematology (2 papers)Clinical Cancer Research (1 paper)
- Partner nations
- GermanyAustriaUnited States
In The Last Decade
Guido Bisping
28 papers receiving 825 citations
Peers
Comparison fields: 5 of 70
- Hematology 428
- Oncology 254
- Genetics 78
- Internal Medicine 23
- Molecular Biology 372
Countries citing papers authored by Guido Bisping
This map shows the geographic impact of Guido Bisping's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guido Bisping with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guido Bisping more than expected).
Fields of papers citing papers by Guido Bisping
This network shows the impact of papers produced by Guido Bisping. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guido Bisping. The network helps show where Guido Bisping may publish in the future.
Co-authors
The 25 scholars most cited alongside Guido Bisping, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 124 | |
| 2 | 2003 | 100 | |
| 3 | 2003 | 97 | |
| 4 | 2009 | 78 | |
| 5 | 2001 | 62 | |
| 6 | 2005 | 43 | |
| 7 | 2016 | 33 | |
| 8 | 2005 | 28 | |
| 9 | 2009 | 28 | |
| 10 | 2009 | 27 | |
| 11 | An open-label dose-escalation study of BIBF 1120 in patients with relapsed or refractory multiple myeloma. | 2009 | 27 |
| 12 | 2004 | 24 | |
| 13 | 2006 | 23 | |
| 14 | 2014 | 23 | |
| 15 | 2006 | 23 | |
| 16 | 2005 | 20 | |
| 17 | 2007 | 18 | |
| 18 | 1999 | 16 | |
| 19 | 2017 | 14 | |
| 20 | 2001 | 14 |
About Guido Bisping
Guido Bisping is a scholar working on Hematology, Oncology, Molecular Biology, Surgery and Pathology and Forensic Medicine, having authored 28 papers that have together received 847 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (10 papers), Protein Degradation and Inhibitors (3 papers), Cancer Treatment and Pharmacology (3 papers), Hematopoietic Stem Cell Transplantation (3 papers), Immune Cell Function and Interaction (3 papers), Chronic Myeloid Leukemia Treatments (3 papers), Venous Thromboembolism Diagnosis and Management (2 papers) and T-cell and B-cell Immunology (2 papers). The work is most often cited by research in Hematology (428 citations), Oncology (254 citations), Genetics (78 citations), Internal Medicine (23 citations) and Molecular Biology (372 citations). Guido Bisping has collaborated with scholars based in Germany, Austria and United States. Frequent co-authors include Wolfgang E. Berdel, Joachim Kienast, Martin Kropff, Gabriele Koehler, Athanasios Tragiannidis, Andreas H. Groll, Nicola Lang, Rolf M. Mesters, M. Hentrich and Achim Heinecke. Their work appears in journals such as Blood, Annals of Hematology, International Journal of Cancer, British Journal of Haematology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.